10th Cir. Reverses Award of Summary Judgment to Aventis in Clomid Birth Defect Action



DOCUMENTS
  • Opinion


DENVER — A federal appeals court has reversed an award of summary judgment to the maker of Clomid and remanded the action so the lower court can address the drug maker’s failure to adopt the FDA’s proposed warning regarding the risk of harm to the fetus when the drug is taken during pregnancy.

On May 2, the 10th Circuit U.S. Court of Appeals also directed the lower court to explain why federal law preempts the plaintiffs’ claims for fraud, negligent misrepresentation, and breach of an implied warranty.

In 1967, the FDA approved Clomid (clomiphene citrate), a selective-estrogen-receptor modulator, for the …

FIRM NAMES
  • Shook Hardy & Bacon
  • Wagstaff & Cartmell





UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024

MORE DETAILS



HarrisMartin's Masters of Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS